GlassScriptPhysician profile
Kelli M Hendley
NPI 1487164380
$1,925.23
in general payments reported to CMS, 2019-2025
16 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $183 · 2022: $375 · 2023: $398 · 2024: $618 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,367.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,367.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $635.30 | 2021-2025 | Wavewriter Alpha Prime 16, General - Pain Management |
| Abbott Laboratories | $548.25 | 2021-2025 | Proclaim, Eterna |
| Medtronic, INC. | $171.67 | 2022-2025 | Inceptiv |
| Collegium Pharmaceutical, INC. | $153.13 | 2024 | Belbuca, Nucynta |
| Abbvie INC. | $87.46 | 2024 | |
| Globus Medical, INC. | $71.27 | 2025 | Senza |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $52.79 | 2023-2025 | Relistor |
| Vertos Medical, INC. | $35.26 | 2021 | |
| Biotronik Nro, INC. | $28.08 | 2025 | Prospera |
| Spr Therapeutics, INC | $23.83 | 2024 | Sprint Pns System |
| Forte Bio-Pharma LLC | $23.28 | 2024 | Prolate, Nalocet |
| Ossdsign USA Incorporated | $20.65 | 2025 | Ossdsign Catalyst |
| Si-Bone, INC. | $20.17 | 2021 | |
| Painteq LLC | $19.25 | 2024 | Painteq |
| Saluda Medical Americas, INC. | $18.89 | 2025 | Evoke |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $15.95 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Hendley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.